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Self-tolerance to immune reactions is established via
promiscuous expression of tissue-restricted anti-
gens (TRAs) in medullary thymic epithelial cells
(mTECs), leading to the elimination of T cells that
respond to self-antigens. The transcriptional regu-
lator Aire has been thought to be sufficient for the in-
duction of TRAs, despite some indications that other
factors may promote TRA expression in the thymus.
Here, we show that the transcription factor Fezf2
directly regulates various TRA genes in mTECs inde-
pendently of Aire. Mice lacking Fezf2 in mTECs dis-
played severe autoimmune symptoms, including
the production of autoantibodies and inflammatory
cell infiltration targeted to peripheral organs. These
responses differed from those detected in Aire-defi-
cient mice. Furthermore, Fezf2 expression and Aire
expression are regulated by distinct signaling path-
ways and promote the expression of different clas-
ses of proteins. Thus, two independent factors,
Fezf2 and Aire, permit the expression of TRAs in
the thymus to ensure immune tolerance.INTRODUCTION
In all vertebrates, T cells are generated in the thymus, and their
antigen receptors are generated through random somatic DNA
rearrangement, which provides amolecular basis for recognizing
and eliminating an essentially unlimited number of pathogens
(Anderson and Takahama, 2012; Hogquist et al., 2005; Klein
et al., 2014). However, this process inevitably gives rise to the
production of self-reactive T cells. To prevent autoimmune dis-
ease, immune reactions against self-antigens must be sup-
pressed through central and peripheral tolerance (Sakaguchi
et al., 2006). The repertoire of T cell receptors (TCRs) that
potently react self-components is removed in the thymus, a pro-
cess that comprises the fundamental mechanism of central
tolerance (Kappler et al., 1987).T cell differentiation and repertoire selection are dependent
on the thymic microenvironment, mainly supported by thymic
epithelial cells (TECs) and dendritic cells (Gallegos and Bevan,
2004; Hinterberger et al., 2010). After positive selection by
cortical thymic epithelial cells (cTECs) based on the proper affin-
ity to major histocompatibility complex (MHC) molecules, T cells
migrate to the medulla and undergo negative selection (Klein
et al., 2014). mTECs promiscuously express peripheral tissue-
restricted antigens (TRAs) (Derbinski et al., 2001) and T cells
that potently react to these antigens are eliminated by apoptosis.
The transcriptional regulator Aire has been shown to be essential
for the promiscuous TRA expression and negative selection (Lis-
ton et al., 2003; Mathis and Benoist, 2009), since autoimmune
symptoms manifest in both Aire-deficient (Aire/) mice (Ander-
son et al., 2002) and patients with autoimmune polyendocrinop-
athy candidiasis ectodermal dystrophy (APECED) caused by
mutations of the AIRE gene (Akirav et al., 2011). Aire expression
is regulated by members of the tumor necrosis factor receptor
superfamily such as Tnfrsf11a (also known as receptor activator
of nuclear factor-kB; RANK) and CD40. In more than 10 years
since the discovery of AIRE (Aaltonen et al., 1997; Nagamine
et al., 1997), TRA expression in the thymus has been thought
to be exclusively dependent on Aire. However, there are TRA
genes that are induced in the absence of Aire (Derbinski et al.,
2005), raising the possibility that other transcriptional regulators
are functional in the induction of self-antigens in mTECs.
Here, we investigated the transcriptional regulators of TRAs in
mTECs and report the identification of the key transcription fac-
tor Fezf2 (also known as Zfp312 and Fezl). Fezf2 plays an indis-
pensable role in the expression of TRAs and the establishment of
immune tolerance independently of Aire. The parallel RANK/
CD40 and lymphotoxin beta receptor (LTbR) signaling pathways
were shown to regulate the expression ofAire and Fezf2, respec-
tively. Thus, these findings constitute an important advance in
the current understanding of immune tolerance and the mecha-
nisms underlying autoimmune diseases.
RESULTS
Fezf2 Is Highly Expressed in Mouse and Human mTECs
As mTECs express TRAs in the absence of Aire (Derbinski et al.,
2005), we hypothesized that there are additional transcriptionalCell 163, 975–987, November 5, 2015 ª2015 Elsevier Inc. 975
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Figure 1. Loss of Fezf2 in the Mouse mTEC Leads to Autoimmunity
(A) qRT-PCR analysis of Fezf2 mRNA expression (relative to Gapdh) in various cell types in the mouse thymus (3-week-old, n = 6). Error bars indicate the
mean ± SD. ND, not detected.
(B and C) Flow cytometric analysis of Fezf2 and Aire protein expression in mTECs (B) or in the mTEClo (MHC IIlow) andmTEChi (MHC IIhigh) populations (C). mTECs
were identified as EpCAM+ and MHC class II+ (MHC II+) among the CD45– and Ly51– cells. Gray plots, the negative control.
(D and E) Immunohistochemical analysis of Fezf2 expression in keratin 5+ (Krt5+) mTECs (D) and Fezf2 and Aire expression in themedulla (E) of themouse thymus.
(F) FEZF2 expression in KRT5+ mTECs in human fetal thymus (29-week-old, male). The bottom panels are enlarged views of the upper panels. Scale bars in
(D)–(F), 100 mm.
(G) Experimental design used for thymus transplantation (top) and macroscopic images of the thymus-grafted nude mouse (bottom left) and kidneys (bottom
right). The arrowhead indicates the grafted thymus under the renal capsule.
(H) Morphological analysis of grafted thymus (H&E staining).
(I) CD4/CD8 differentiation of thymocytes in WT/nu and KO/nu mice (n = 3).
(J) Gross anatomy (top) and weight (bottom) of spleens from the WT/nu and KO/nu mice (n = 9). Scale bar, 5 mm. Data are shown as the mean ± SD. **p < 0.01.
(K) Structure of the spleen and lymph nodes of WT/nu and KO/nu mice (H&E staining). Arrowheads, follicles in the spleen; TZ, T cell zones in the inguinal lymph
nodes.
(legend continued on next page)
976 Cell 163, 975–987, November 5, 2015 ª2015 Elsevier Inc.
regulators that are responsible for the induction of TRAs in the
mTEC. To identify the genes selectively expressed in mTECs,
we analyzed the GeneChip data on the mRNA isolated from
mTECs and cTECs. Among a group of genes that were ex-
pressed 20-fold higher in mTECs than cTECs, only Fezf2 was
categorized as a transcriptional regulator (Figure S1A); thus,
we focused on it as a potential mTEC-specific transcriptional
regulator. Intriguingly, the expression level of Fezf2 was as
high as that of Aire in mTECs (Figure S1B).
Fezf2 was originally discovered in the developing forebrain of
Xenopus and zebrafish (Eckler and Chen, 2014). Fezf2 contains
the evolutionarily conserved six zinc finger domains (Figure S1C)
and has been shown to be a neuronal transcription factor
required for the differentiation and specification of corticospinal
neurons and other subcerebral projection neurons in the brain
(Shim et al., 2012), but no immunological function has been re-
ported to date.
To examine Fezf2 gene expression in the mouse thymus, we
performed qRT-PCR analysis and showed that Fezf2 mRNA
was specifically expressed in mTECs among the various thymic
cell types (Figure 1A). The expression of Fezf2 was develop-
mentally induced during the perinatal period (Figure S1D).
The development of mTECs is characterized by the upregula-
tion of CD80 and MHC class II (Gray et al., 2006), the expres-
sion of which determines whether mTECs belong to either the
mTEChi or mTEClo population. mTEChi cells functionally pro-
duce thousands of TRAs for the negative selection of T cells
(Derbinski et al., 2005; Sansom et al., 2014). Flow cytometric
analysis revealed that Fezf2 is expressed in 30% of the mTEClo
population and almost all of the mTEChi population (Figures 1B
and 1C). Immunostaining clearly indicated that Fezf2 is ex-
pressed by mTECs positive for keratin 5, but not cTECs (Fig-
ure 1D), while almost all of the the Aire-expressing cells were
positively stained for Fezf2 (Figure 1E). When we transiently
overexpressed Fezf2 and Aire in an mTEC line, the Fezf2 pro-
tein specifically located in the nucleus but did not colocalize
with Aire (Figure S1E). In the human thymus, immunohisto-
chemical analysis showed that FEZF2 was selectively ex-
pressed in keratin 5-positive mTECs (Figure 1F), and AIRE
was expressed in the FEZF2-positive cells (Figure S1F). These
data clearly imply that Fezf2 plays a functional role in mouse
and human mTECs.
Fezf2 Deficiency Leads to the Infiltration of
Inflammatory Cells
Fezf2-deficient (Fezf2/) mice have a brain development
defect and fail to survive after weaning due to an inability to
consume solid food (Hirata et al., 2004). The mice die at
4 weeks of age, prior to the obvious manifestation of immuno-
logical symptoms. Thus, we tested the immunological function
of thymic stromal cells by transplantation of hematopoietic-cell-
depleted thymuses into the renal capsule of nude mice (Ander-
son et al., 2002). Eight weeks later, the successful engraftment(L) Inflammatory cell infiltration in the lung, liver, kidney (arrowheads), and small
(M) Schematic of inflammatory cell infiltration into the peripheral tissues of WT/nu
blue triangle indicates the detection of inflammatory cell infiltration in the organ.
See also Figure S1.was observed in the nude mice grafted with the Fezf2/
thymus (KO/nu) as well as in the nude mice grafted with control
littermate thymus (WT/nu) (Figure 1G). There was no difference
in Aire expression (Figure S1G) or thymic size between the KO/
nu and WT/nu mice (Figure 1H). Flow cytometric analysis re-
vealed a normal differentiation of CD4 and CD8 thymocytes
in the engrafted thymuses (Figure 1I), while the number of
Foxp3+ regulatory T (Treg) cells was slightly decreased in KO/
nu mice (Figure S1H). KO/nu mice exhibited splenomegaly
with an increased number of follicles as well as an expansion
of the T cell zone in the lymph nodes (Figures 1J and 1K). An
infiltration of inflammatory cells, including lymphocytes, was
observed in peripheral tissues, including the lung, liver, kidney,
and small intestine (Figures 1L and 1M). However, there was
no obvious inflammatory cell infiltration into the pancreas or
retina (Figure S1I), which are highly affected in Aire/ mice
(Anderson et al., 2002).
Thymocyte and mTEC Development in Fezf2/ Mice
To examine the function of Fezf2 in the development of mTECs
and thymocytes, Fezf2/ mice were analyzed before weaning,
at the 3weeks of age. Keratin 5-positivemTECswere abnormally
distributed in clusters in the thymic medulla of the Fezf2/mice
as compared to the wild-type (WT) mice (Figures 2A, S2A, and
S2B). The cTEC number was unchanged (Figure S2C), but the
mTEC number and the ratio of mTECs (CD80+ cells) to total
TECs (EpCAM+CD45 cells) were decreased in Fezf2/ mice
(Figures 2B, 2C, and S2D). However, there was no significant dif-
ference in the ratio of mTEChi and mTEClo (Figures 2D and S2E)
or in Aire protein as well as mRNA expression in mTECs (Figures
2E and 2F) between WT and Fezf2/ mice. Collectively, these
results suggest that Fezf2 is not involved in the regulation of
Aire expression in mTECs or the mTEChi/lo ratio, although thymic
organization and the mTEC number are slightly influenced by
Fezf2 deficiency. The differentiation of thymocytes into CD4+
or CD8+ T cells was normal (Figure 2G), while the ratio of
Foxp3+ to CD4+ thymocytes was modestly decreased in
Fezf2/ mice (Figure 2H). We found that Fezf2/ mice ex-
hibited shifts in the CD4+ and CD8+ TCRVb repertoire in the
thymus (Figure 2I), suggesting a crucial role of Fezf2 in shaping
the TCR repertoire of CD4+ and CD8+ T cells.
Fezf2 Controls TRA Expression Independently of Aire
How does Fezf2 contribute to thymic gene expression? We per-
formed a genome-wide analysis of mRNAs expressed in the
mTECs isolated from Fezf2/ mice and selected genes that
were expressed more than four times higher in the WT than the
Fezf2/ mTECs (Figure 3A). All of the 16 Fezf2-dependent
genes belonged to TRAs, which are expressed in specific pe-
ripheral tissues according to the BioGPS gene annotation portal
(http://biogps.org/#goto=welcome), and are thus regarded as
Fezf2-dependent TRAs (Table S1). Interestingly, five of these
Fezf2-dependent TRAs (Krt10, Resp18, Fabp9, Maoa, andintestine (S. int) of the KO/nu mice (H&E staining).
and KO/nu mice. Each hexagon represents a single grafted mouse (n = 9). The
Scale bars in (H), (K), and (L), 200 mm.
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Figure 2. Fezf2 Shapes the Repertoire of T Cell Receptors
(A) Distribution of mTECs and Aire protein expression in the WT and Fezf2/ thymus. C and M represent the cortex and medulla, respectively, and the
arrowheads indicate clustered Krt5-positive mTECs. Scale bars, 100 mm.
(B) The ratio of the total mTECs (CD80+ cells) to TECs (CD45EpCAM+ cells) (WT, n = 8; Fezf2/, n = 9).
(C) The total mTEC number in WT and Fezf2/mice (n = 8 per genotype).
(D) The ratio of mTEChi and mTEClo (MHCIIhi and MHCIIlo) among the total mTECs (CD45Ly51–MHCII+EpCAM+ cells) (WT, n = 3; Fezf2/, n = 4).
(E) Aire protein expression in mTECs inWT and Fezf2/mice. The numbers above the lines indicate the ratio of Aire+ cells to the total mTECs (WT, n = 6; Fezf2/,
n = 8).
(F) Aire mRNA expression in mTECs (WT, n = 10; Fezf2/, n = 8).
(G) The normal differentiation of thymocytes into CD4+ or CD8+ T cells (WT, n = 10; Fezf2/, n = 8).
(H) The ratio of Foxp3+ cells to CD4+ thymocytes (WT, n = 6; Fezf2/, n = 5).
(I) The usage of TCRVb on CD4+ or CD8+ T cells in the thymus (WT, n = 10; Fezf2/, n = 8;Aire/, n = 5). Data are shown as themean ±SD. NS, not significant (p >
0.05); *p < 0.05; **p < 0.01.
See also Figure S2.Timd2) had already been reported to be induced in the absence
of Aire, i.e., Aire-independent TRA genes (Derbinski et al., 2005).
These data suggest that Fezf2 regulates the expression of a
distinct subset of TRAs in the thymus. On the other hand,
there were no significant differences in the expression of MHC
class I and II molecules (H2-D, H2-K, and H2-A, H2-E, respec-
tively), costimulatorymolecules (Cd80 andCd86), invariant chain978 Cell 163, 975–987, November 5, 2015 ª2015 Elsevier Inc.(Cd74), chemokines (Xcl1 [Lei et al., 2011] andCcl21 [Laan et al.,
2009]) or mTEC terminal differentiation marker Ivl (Nishikawa
et al., 2010) (Figures S3A–S3E).
qRT-PCR analysis revealed that mRNA expression of the
Fezf2-dependent TRAs was not reduced in the mTECs iso-
lated from Aire/mice (Figure 3B). The expression of represen-
tative Aire-dependent genes (Spt1, Ins2, Mup4, and S100a8)
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Figure 3. Fezf2 Regulates a Subset of TRA
Genes in an Aire-Independent Manner
(A) Fezf2-dependent genes in mTEC based on
mRNA expression profiling of mTECs from WT
and Fezf2/ (KO) mice (n = 5 per genotype). Listed
are the 16 most highly downregulated genes in
Fezf2/ mTECs compared with WT mTECs. The
genes that have been reported as Aire-indepen-
dent TRA genes are shown in red. Genes ex-
pressed in a single tissue are highlighted in blue
shading.
(B) Comparison of mRNA expression of Fezf2-
dependent TRA genes in WT, Aire/, and Fezf2/
mTECs.
(C) The mRNA expression of representative Aire-
dependent TRA genes in WT, Aire/, and Fezf2/
mTECs. The data in (B) and (C) are shown as the
mean ± SD, *p < 0.05 versus WT (WT, n = 4;
Fezf2/, n = 3; Aire/, n = 5); ND, not detected.
(D) Chromatin immunoprecipitation (ChIP) assay.
Fezf2 binds to the promoter region of Fezf2-
dependent but not Aire or Aire-dependent TRA
genes.
(E) A comparison of the Fezf2-dependent and Aire-
dependent genes. Most of the Fezf2-dependent
genes are different from the Aire-dependent genes
collected from the database (GeneChip data:
GSE69105 and GSE85; fold change [FC] >1.5, p <
0.05).
(F) Luciferase assay in an mTEC line 1C6. The
expression of Fezf2-dependent TRA genes (Maoa,
Calb1, and Nol4) is controlled by Fezf2, but
not by N-terminus-deleted Fezf2 (Fezf2DN) or C-
terminus-deleted Fezf2 (Fezf2DC). Luciferase vec-
tors: empty pNluc vector (NL) or pNluc vectors
containing the promoter region of Maoa, Calb1,
or Nol4. Data in (D) and (F) are shown as the
mean ± SD, *p < 0.05, **p < 0.01, ***p < 0.001.
See also Figure S3.(Waterfield et al., 2014) was not significantly decreased in
Fezf2/ mice (Figure 3C). In addition, microarray analysis re-
vealed that the downregulated genes in the Fezf2/ mTECs
were for the most part different from those downregulated in
Aire/ (Figure 3D). The expression of most of the Fezf2-depen-
dent genes was higher in mTEChi than mTEClo (Figure S3F),
consistent with the higher expression of Fezf2 in mTEChi (Fig-Cell 163, 975–987,ure 1C). Bioinformatics analysis revealed
that Aire and/or Fezf2 control over 60%
of the mTEC-specific TRAs (Figure S3G).
The genes downregulated in Fezf2/
mTECs included certain TRAs related
to autoimmune or neoplastic diseases
(Endo et al., 2009; Fatourou and Koskinas,
2009; Roulois et al., 2013) (Figure S3H).
These results show that Fezf2 regulates
a unique subset of TRA genes indepen-
dently of Aire.
A recent global chromatin immunopre-
cipitation sequencing (ChIP-seq) analysis
revealed that Fezf2 binds to the promoterof numerous protein-coding genes in cortical progenitors (Lo-
dato et al., 2014). Our ChIP assay demonstrated that Fezf2
directly bound to the promoter region of Fezf2-depenedent
TRA genes, but not to that of the Aire or Aire-dependent TRA
genes in mTECs (Figure 3E). Additionally, we found Fezf2 bound
to the promoter region of certain TRA genes such asMbp,Gad1,
Col2a1, andMuc1, which are known to be autoantigens or tumorNovember 5, 2015 ª2015 Elsevier Inc. 979
12.5±1.2% 26.8±4.7%*
CD62L
C
D
44
4.2±0.8% 2.2±0.9%*
A
B
D
E
F
42±4%45±3%
CD8α
C
D
4
CD8 8.5±2.4%**3.8±0.7%
control
α-Aire
CD25
Fo
xp
3
CD4
Aire
%
 o
f m
ax
Fezf2fl/+ Fezf2fl/-
Foxn1-Cre+
G
C
Fezf2fl/+ Fezf2fl/-
Foxn1-Cre+
Fezf2fl/+ Fezf2fl/-
Foxn1-Cre+
12.2±1.8% 7.5±1.1%*
CD25
Fo
xp
3
CD4
Fezf2fl/+ Fezf2fl/-
Foxn1-Cre+
62±4% 39±3%*
CD80
E
pC
A
M
Fezf2fl/+ Fezf2fl/-
Foxn1-Cre+
Fezf2fl/+ Fezf2fl/-
Foxn1-Cre+
0
10
20
30
40
50
60 **
0
3
6
9
12
**
Fezf2fl/+
Fezf2fl/-
Foxn1-Cre+
C
el
ls
 (×
 1
07
)
C
el
ls
  (
× 
10
6 )
Fezf2fl/+
Fezf2fl/-
Foxn1-Cre+
Spleen LN
H
0
50
100
150
200
250
4 weeks 20 weeks
*
Foxn1-Cre+ Fezf2fl/-Fezf2fl/+
C
cl
2 
in
 s
er
um
 (p
g/
m
l)
*
Aire
Krt5
Fezf2fl/+ Fezf2fl/-
Foxn1-Cre+
Aire
Krt5
I
Figure 4. Analyses of Lymphoid Organs in
TEC-Specific Fezf2-Deficient Mice
(A) Localization of mTECs in the thymic medulla in
Foxn1-Cre+ Fezf2fl/– mice. The arrowhead indicates
the clustered mTECs. Scale bars, 100 mm.
(B) The ratio of mTECs (CD45, EpCAM+, and
CD80+ cells) to the total TECs (n = 8 per genotype).
(C) Aire protein expression in mTECs (n = 6 per
genotype).
(D) CD4/CD8 differentiation of thymocytes (n = 12
per genotype).
(E) The ratio of Foxp3+CD25+ CD4 T cells in the
thymus (n = 12 per genotype).
(F) The increased number of T cells in spleen and
lymph nodes (LN) in Foxn1-Cre+ Fezf2fl/– mice (n = 4
per genotype).
(G) The elevated ratio of CD62LloCD44hi effector/
memory T cells in Foxn1-Cre+ Fezf2fl/– mice (n = 6
per genotype).
(H) The reduced ratio of Foxp3+CD25+ CD4 T cells
in the LN of Foxn1-Cre+ Fezf2fl/– mice (n = 6 per
genotype).
(I) The serum Ccl2 (MCP-1) level measured by
cytometry beads assay (n = 5 per genotype).
Data are shown as the mean ± SD. *p < 0.05; **p <
0.01.
See also Figure S4.antigens (Figure S3I) (Ali et al., 2011; Belogurov et al., 2008; Ko-
matsu et al., 2014; Roulois et al., 2013). Luciferase reporter
assay revealed that Fezf2 regulates the expression of Maoa,
Calb1, andNol4 genes (Figure 3F). Therefore, these data indicate
that Fezf2 directly binds to the promoter region and controls
the gene expression of distinct TRAs in an Aire-independent
manner.
The Generation and Immunological Analysis of
TEC-Specific Fezf2-Deficient Mice
We generated the TEC-specific Fezf2-deficient (Foxn1-Cre+
Fezf2fl/–) mice and further examined the role of Fezf2 in auto-980 Cell 163, 975–987, November 5, 2015 ª2015 Elsevier Inc.immunity. In accordance with the find-
ings in the Fezf2/ mice, keratin 5-pos-
itive mTECs were also abnormally
distributed in clusters in the thymic
medulla of Foxn1-Cre+ Fezf2fl/– mice
(Figure 4A). Both the mTEC number
and the fraction of mTECs among the
total TECs were decreased (Figures 4B
and S4A). However, the expression of
Aire in the mTECs (Figure 4C) and the
ratio of mTEChi and mTEClo (Fig-
ure S4B) were unaffected in Foxn1-Cre+
Fezf2fl/– mice. The differentiation of thy-
mocytes into CD4+ or CD8+ T cells in
the thymus was unaltered (Figure 4D).
B cells differentiated normally in the
bone marrow, spleen, and lymph nodes
(Figures S4C–S4E). There was a modest
reduction in the ratio of Foxp3+CD25+ toCD4+ cells in the Foxn1-Cre+ Fezf2fl/– thymus (Figures 4E and
S4F). The percentage of CD4+ and CD8+ T cells was un-
changed (Figure S4G), but the T cell number was significantly
elevated in the spleen and lymph nodes of the Foxn1-Cre+
Fezf2fl/– mice (Figure 4F). The Foxn1-Cre+ Fezf2fl/– mice
showed an elevated proportion of CD44hiCD62L– effector/
memory T cells (Figure 4G), while the percentages of
Foxp3+CD25+ Treg cells were reduced in the lymph nodes
(Figure 4H). The Foxn1-Cre+ Fezf2fl/– mice had a higher serum
level of Ccl2 (also known as Mcp-1) (Figure 4I), a chemokine
that induces the migration and infiltration of monocytes and
T cells (Deshmane et al., 2009).
TEC-Specific Fezf2-Deficient Mice Display Autoimmune
Symptoms, Including Autoantibody Production and
Peripheral Organ Inflammation
We analyzed the infiltration of inflammatory cells, including lym-
phocytes, into peripheral tissues, aswell as autoantibodies in the
sera of Foxn1-Cre+ Fezf2fl/– mice. Inflammatory cell infiltration
was detected in the lung, liver, kidney, stomach, small intestine,
salivary gland, brain, and testis of Foxn1-Cre+ Fezf2fl/– mice (Fig-
ure 5A). Thus, the spectrum of autoimmune target tissues was
found to be wider than that of Aire/mice. There was, however,
no obvious inflammatory cell infiltration into the pancreas or
retina, which is consistent with the observation in KO/nu mice
(Figure S1I). Foxn1-Cre+ Fezf2fl/– mice exhibited hypergamma-
globulinemia (Figure S5). To assess whether the sera from KO/
nu or Foxn1-Cre+ Fezf2fl/– mice contained autoantibodies, we
immunostained various tissues derived from Rag1/ mice
with the sera. Antibody reactivity was detected in both KO/nu
and Foxn1-Cre+ Fezf2fl/– sera against the lung, retina, skin, and
joint tissues, but the staining patterns were different from
that of Aire/ serum (Figure 5B), suggesting that Fezf2/ and
Aire/mice have autoantibodies recognizing distinct tissue an-
tigens. The staining pattern of the serum from Foxn1-Cre+
Fezf2fl/– mice was much broader than that of Aire/. Approxi-
mately 30% of the TEC-specific Fezf2-deficient mice (five of
16) died by 12 months, whereas all of the Aire/ mice survived
for more than 16 months after birth (20/20), implying the autoim-
mune symptoms in the case of Fezf2 deficiency were more
severe than that in Aire/ deficiency. The serum from Foxn1-
Cre+ Fezf2fl/– mice contained significantly increased autoanti-
bodies that recognize recombinant proteins of the Fezf2-depen-
dent TRAs, Ttr, Maoa, and Clab1, as compared to the sera
from WT and Aire/ mice (Figure 5C). In contrast, the serum
from the Foxn1-Cre+ Fezf2fl/– mice was not reactive to Aire-
dependent TRAs, such as Irbp (DeVoss et al., 2006) (Figure 5C).
Taken together, we conclude that Fezf2 functions in mTECs to
ensure immunological tolerance against certain tissue antigens
and effectively suppresses the development of autoimmune
responses.
Fezf2 Is Regulated by the LTbR Pathway, but Not by the
RANK/CD40 Pathways or Aire
The receptors of the TNF superfamily are required for the forma-
tion of the thymic microenvironment and central tolerance. For
example, the RANK and CD40 signaling pathways are essential
for mTEC development and Aire expression (Akiyama et al.,
2008). Therefore, we examined the expression of Fezf2 in
mice deficient in Tnfrsf11 (encoding RANK) and Cd40. Fezf2-
expressing cells were normally observed upon immunohisto-
chemical analysis and Fezf2 mRNA expression was unaffected
in Foxn1-Cre+ Tnfrsf11afl/– mice (Figures S6A–S6C) as well as
Cd40/ mice (Figures S6D–S6F). Normal Fezf2 expression
was also observed in mice deficient in Tnfsf11 (encoding
RANKL) (Figures 6A and 6B). To examine the possibility that
Aire controls Fezf2 expression, we analyzed Aire/ mice and
found no difference in Fezf2 expression between the WT and
Aire/ mice (Figures 6C–6E). These results indicate that
Fezf2 expression is not regulated by either the RANK/CD40
pathways or Aire.Both TNF-receptor-associated factor 6 (Traf6) and LTbR sig-
naling critically contribute to mTEC differentiation in the estab-
lishment of the medullary microenvironment and central toler-
ance (Akiyama et al., 2005; Boehm et al., 2003). Traf6/ mice
displayed a significant reduction in Fezf2 mRNA and protein
expression in the thymus (Figures S6G and S6H). The ratio of
mTEC to the total TECs was significantly decreased in Ltbr/
mice (Figure 6F), and Fezf2 mRNA and protein expression was
decreased in the Ltbr/ mTECs (Figures 6G–6I). Consistent
with this, the expression of the Fezf2-dependent TRA genes
Krt10, Fabp9, Calb1, and Nol4 were markedly decreased
(Figure 6J), while the expression of Aire-dependent TRAs as
well as Aire itself were unaffected in the Ltbr/mTECs (Martins
et al., 2008; Venanzi et al., 2007). Thus, Fezf2 expression is
induced by the LTbR pathway independently of the RANK/
CD40 pathways or Aire.
DISCUSSION
The Discovery of a Key Transcription Factor Involved in
the Establishment of Central Tolerance
In this study, it has been demonstrated that Fezf2, which is
exclusively expressed in mTECs in the thymus, regulates TRA
expression independently of Aire. Mice specifically lacking
Fezf2 in mTECs develop severe autoimmune phenotypes, with
autoantibody production and inflammatory cell infiltration.
Notably, Fezf2 and Aire play non-redundant roles in the TRA
expression that is crucial for the elimination of self-reactive
T cells (Figure 7). Thus, Fezf2 functions in the thymus as an
mTEC-specific transcription factor required for the establish-
ment of central tolerance, thereby playing a key role in the regu-
lation of untoward immunological reactions.
Distinct Function of theRANK/CD40 andLTbRPathways
in the Expression of TRAs in mTECs
The TNF receptors RANK, CD40, and LTbR are required for
central tolerance and TRA expression (Akiyama et al., 2008;
Martins et al., 2008). The RANK and CD40 signaling pathways
regulate Aire expression and the development of mTECs, and
Spi-B is involved in the differentiation of mTEClo to mTEChi
downstream of the RANK signaling (Akiyama et al., 2014). The
LTbR signaling pathway is needed for the formation of normal
thymic architecture and mTEC differentiation (Boehm et al.,
2003; Venanzi et al., 2007; White et al., 2010), but Ltbr defi-
ciency does not affect either Aire expression or Aire-dependent
TRA gene expression in mTECs (Seach et al., 2008). The
evidence obtained in this study shows that Fezf2 is a trans-
criptional regulator that is induced downstream of the LTbR
signaling, and that Fezf2 regulates the expression of certain
genes (Figure 3) but is not involved in the differentiation of
mTEClo to mTEChi (Figures 2D and S4B). Fezf2-dependent
TRA expression, but not Aire-dependent TRA expression, was
decreased in Ltbr/ mTECs (Figure 6J). Thus, RANK/CD40
and LTbR regulate the induction of distinct TRA genes through
Aire and Fezf2, respectively.
It will be of considerable interest to investigate why there are
two pathways for the establishment of central tolerance in
mTECs. The LTbR signaling pathway is essential for lymphoidCell 163, 975–987, November 5, 2015 ª2015 Elsevier Inc. 981
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Figure 5. Tissue Infiltration and Autoantibody Produc-
tion in TEC-Specific Fezf2-Deficient Mice
(A) Inflammatory cell infiltration in the peripheral tissues in the
Foxn1-Cre+ Fezf2fl/– mice. Infiltration was detected in lung,
liver, kidney (arrowheads), and small intestine (S. int), but not in
the retina or pancreas (H&E staining).
(B) Detection of autoantibody reactivity in the serum of Foxn1-
Cre+ Fezf2fl/– mice. Sections of tissues from Rag1/ mice
were stained with sera from WT/nu, KO/nu, Aire/, or Foxn1-
Cre+ Fezf2fl/– mice followed by a secondary antibody labeled
with Alexa 555. Serum was collected from Aire/ or Foxn1-
Cre+ Fezf2fl/– mice at the age of 20 weeks. Scale bars in (A) and
(B), 200 mm.
(C) Detection of autoantibodies against Fezf2-dependent (Ttr,
Maoa, and Calb1) or Aire-dependent (Irbp) TRAs in the serum
from Foxn1-Cre+ Fezf2fl/– mice (ELISA, n = 6 per genotype).
Data are shown as the mean ± SD. *p < 0.05; **p < 0.01.
See also Figure S5.
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organogenesis, while the RANK and CD40 signaling pathways
are required for bone homeostasis and the T-cell-mediated B
cell response, respectively (Locksley et al., 2001). Although
the Fezf2 gene is conserved in all vertebrates (Eckler and
Chen, 2014) that have lymphoid organs (Hofmann et al., 2010;
Takaba et al., 2013), the Aire gene is conserved only in jawed
vertebrates (Saltis et al., 2008). During the course of evolution,
the LTbR-Fezf2 axis might have emerged as the primitive
pathway for immune tolerance, while the RANK/CD40-Aire
axis emerged later to perform certain critical functions not car-
ried out by Fezf2.
Direct Transcriptional Regulation of TRAGenes by Fezf2
Aire does not have an obvious DNA binding domain and is not
regarded as authentic transcription factor (Abramson et al.,
2010; Giraud et al., 2014). Aire interacts with several nuclear
factors such as hypomethyrated histone H3 (Koh et al.,
2010) and the ATF7ip-MBD1 protein complex (Waterfield
et al., 2014), unleashing the stalled RNA polymerases in order
to epigenetically promote the ectopic transcription of TRA
genes (Peterson et al., 2008). In contrast, Fezf2 has a DNA
binding domain and directly regulates the expression of a
large number of genes (Eckler and Chen, 2014). Although a
recent global ChIP-seq analysis showed that Fezf2 binds to
the promoters of a large number (over 10,000) of protein-cod-
ing genes (Lodato et al., 2014), Fezf2 does not bind the pro-
moters of Aire or Aire-dependent TRA genes, such as Ins2
(Figures 3D and S3I). While Aire expression is mainly limited
to mTECs, Fezf2 is expressed and plays a role in other organs,
such as the brain. Further studies are necessary to understand
how Fezf2 functions as an inducer of TRA in mTECs. One of
the possibilities is that Fezf2 might interact with mTEC-spe-
cific transcriptional regulator(s) that specifically modulate
chromatin structure and mediate the tissue-specific function
of Fezf2.
By our bioinformatics analysis, most Fezf2-dependent genes
did not overlap with Aire-dependent genes (Figure 3D). Although
some TRA genes might be regulated by Aire and Fezf2 co-oper-
atively, the majority of TRAs were found to be separately
controlled by either Fezf2 or Aire in mTECs (Figure S3G). Since
the expression of certain TRAs was unaffected in both Aire/
and Fezf2/mice, we cannot rule out the possibility that another
transcriptional regulator(s) contributes to the TRA expression in
mTECs.
The Spectrum of Autoimmunity in Fezf2-Deficient Mice
In Fezf2 deficiency, inflammatory cell infiltration was observed
in several peripheral tissues, but not in the retina or pancreas,
which are often affected in Aire deficiency (Figure S1I) (Ander-
son et al., 2002). Antibodies in the sera from KO/nu mice re-
cognized peripheral tissues of Rag1-deficient mice, and the
staining pattern was largely complementary to that of Aire/
mice (Figure 5B). In addition, the serum from Foxn1-Cre+
Fezf2fl/– mice contained significantly increased autoantibodies
that recognize Fezf2-dependent but not Aire-dependent TRAs
(Figure 5B; Table S2). Fezf2 directly binds to the promoter re-
gion of Fezf2-dependent TRA genes in the mTECs, but not to
that of but not Aire-dependent TRA genes (Figure 3E). Thesedata strongly support the conclusion that the Fezf2-deficient
mice have autoimmune reactions in a selective and antigen-
dependent manner, and the failure of clonal deletion causes
the autoimmune phenotypes in Fezf2 deficiency, even though
they exhibited small reductions in the mTEC and thymic Treg
cell number and there was disorganization of mTECs in the me-
dulla. However, since Aire is also involved in mTEC and thymic
Treg cell development (Anderson and Takahama, 2012; Yang
et al., 2015), it will be important in future studies to investigate
how Fezf2 contributes to mTEC development and T cell selec-
tion, including clonal deletion, anergy, and Treg cell differentia-
tion in the thymus.
Association of Fezf2-Dependent TRAs and FEZF2
Mutations with Autoimmune and Neoplastic Diseases
Fezf2-dependent genes included certain TRAs related to auto-
immune diseases or neoplastic diseases (Figures 3A and S3G):
Ttr is related to an autoantibody in rheumatoid arthritis (Sharma
et al., 2014), Amy2a is involved in autoimmune pancreatitis
and fulminant type 1 diabetes (Endo et al., 2009), and Afp and
Muc1 are reported to be tumor antigens in several different
cancers (Fatourou and Koskinas, 2009; Roulois et al., 2013).
Intriguingly, Fezf2-dependent TRAs are mostly categorized as
intracellular or plasma membrane proteins. In contrast, many
Aire-dependent TRAs are secretory proteins (Table S1), which
is consistent with the fact that patients with APECED are afflicted
with endocrine disorders.
It was demonstrated that FEZF2 is highly and specifically ex-
pressed in mTECs among the various types of thymic cells in hu-
mans. Although there is no report in the literature on autoimmune
diseases caused by FEZF2 mutation, certain Fezf2-dependent
TRAs are related to autoimmune diseases and cancers (Endo
et al., 2009; Fatourou and Koskinas, 2009; Roulois et al., 2013;
Sharma et al., 2014) and FEZF2mutations have been associated
with autism (Kwan, 2013; Sanders et al., 2012) and tumors (Shu
et al., 2013). This study has revealed the transcriptional program
in the thymus governed by Fezf2 and Aire, both of which
contribute in an essential manner to the suppression of auto-
immune diseases. Thus, this study represents an important
advance in our understanding of the molecular mechanisms un-
derlying the establishment of central tolerance and the adaptive
immune system.
EXPERIMENTAL PROCEDURES
Mice
Fezf2+/ (CDB0498K) (Hirata et al., 2004) and Ltbr+/ (CDB0531K) (Mouri et al.,
2011) mice were obtained from the animal facility of the Center for Develop-
mental Biology, Riken, Japan (http://www2.clst.riken.jp/arg/mutantmicelist.
html). Aire+/ (stock number, #004743), Foxn1-Cre (#018448), and nude
mice (#000819) were purchased from the Jackson Laboratory. Fezf2fl/fl mice
(Han et al., 2011), Tnfsf11a/mice, and Rag1/ mice were described previ-
ously. Mice were maintained under specific pathogen-free conditions and
handled in accordance with the guidelines for animal experiments of the Uni-
versity of Tokyo.
Flow Cytometric Analysis and Cell Isolation
The following fluorescence-conjugated antibodies were used in the flow cyto-
metric analysis and cell sorting. Flow cytometric analysis was performedwith a
FACSCanto II (BD Biosciences) and FlowJo software (Tree Star). ThymicCell 163, 975–987, November 5, 2015 ª2015 Elsevier Inc. 983
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Figure 6. LTbR Pathway Regulates Fezf2 Expression in mTECs
(A) Fezf2 and Aire protein expression in Tnfsf11+/ and Tnfsf11/ thymus (immunostaining). Right panel, the number of Aire+ and Fezf2+ cells in the thymic
medulla (n = 3 per genotype).
(legend continued on next page)
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Figure 7. A Schematic Model of the Thymic
Program of TRA Expression Regulated by
Fezf2 and Aire
mTEC promiscuously express TRAs, which are
dependent on Fezf2 and Aire. The LTbR pathway
regulates the expression of Fezf2, which directly
induces Fezf2-dependent TRAs by binding to the
promoter of these genes. The RANK/CD40 path-
ways regulate the expression of Aire, which in-
teracts with nuclear proteins (such as histone H3)
and controls the expression of Aire-dependent
TRAs through epigenetic mechanisms. The LTbR-
Fezf2 and RANK/CD40-Aire pathways are both
required for the establishment of immune toler-
ance. PIC, preinitiation complex (including RNA
polymerase II and basal transcription factors).stromal cells were prepared according to a previous report (Hikosaka et al.,
2008), and sorted with a FACSAria III (BD Biosciences).
qRT-PCR
To detect the expression of Fezf2, Aire, and TRA mRNAs, total RNA was ex-
tracted from mTECs using an RNeasy mini or micro kit (Invitrogen). Total
RNAwas subjected to reverse transcriptionwith a first-strand synthesis super-
mix for qRT-PCR (Invitrogen). The amplification conditions were previously
described (Komatsu et al., 2014). The gene expression was normalized by
Gapdh expression.
Microarray Analysis
Total RNA of mTECs isolated by cell sorting from WT mice and Fezf2/
mice was extracted with an RNeasy Micro Kit (QIAGEN) and processed
for microarray analysis, as previously described (Komatsu et al., 2014).
GeneChip analysis was performed using the Affymetrix mouse genome(B) qRT-PCR analysis of Fezf2 mRNA expression in mTECs (n = 3 per genotype).
(C) Flow cytometric analysis of Fezf2 protein expression in mTECs from WT and Aire/mice. Right panel, th
genotype).
(D) Fezf2 mRNA expression in mTECs from WT and Aire/ mice (n = 5 per genotype).
(E) Histochemical analyses of Fezf2 protein expression in the WT and Aire/ thymus. Scale bars, 100 mm.
(F) Flow cytometric analysis of the fraction of mTECs (CD80+ cells) among the total TECs (EpCAM+CD45– ce
(G) The decreased mRNA expression of Fezf2 in Ltbr/ mTECs compared to the WT (n = 4 per genotype).
(H) Fezf2 protein expression in mTECs in Ltbr+/ and Ltbr/ mice (n = 4 per genotype).
(I) Histochemical analyses of Fezf2 protein expression in the Ltbr+/ and Ltbr/ thymus. Scale bars, 100 m
(J) Fezf2-dependent or Aire-dependent TRAmRNA expression in mTECs in Ltbr+/ and Ltbr/mice (n = 4 pe
± SD. NS, not significant; *p < 0.05; **p < 0.01.
See also Figure S6.
Cell 163, 975–987,430 2.0 array. Data were analyzed using Gene-
Spring and deposited in the GEO database
under accession number (GSE69105). Fezf2-
dependent genes (GSE69105) and Aire-depen-
dent genes (GSE85) that are common probes
were picked up from the platforms (total 8,848
coding genes) and compared (cutoff; 1.5-fold, p
value; p < 0.05).
Detection of Inflammatory Cell Infiltration
and Autoantibodies
Organs from the mice were harvested and fixed
with paraformaldehyde (Nacalai), embedded in
paraffin, sectioned, and stained with H&E. Sera
from the WT/nu, KO/nu, Aire/, and Foxn1-Cre+
Fezf2flox/– mice were prepared from tail vein blood.
For the detection of the autoantibodies, serialfrozen sections of the lung, joint, eye, and skin from Rag1/ mice were
incubated with diluted sera in 0.01% Triton-PBS (1:50) followed by Alexa-
Fluor-555-conjugated goat anti-mouse immunoglobulin G (IgG) polyclonal
antibodies (Invitrogen).
Luciferase Reporter Assay
Cells from the mTEC line 1C6 were transfected into pNluc plasmids or pNluc-
the promoters together with Fezf2 expression or control vectors using Lipo-
fectamine 2000 (Invitrogen) and incubated for 24 hr. Signals were detected
with Nano-Glo luciferase assay system (Promega) and quantified with a plate
reader (Berthold MicoLumatPlus LB96V 96well Luminometer).
Cytometric Beads Assay
The mouse inflammatory cytokines or chemokines were detected by cytomet-
ric bead assay kits (BD Biosciences) and analyzed with a FACSCanto II (BD
Biosciences).e mean fluorescence intensity (MFI) ratio (n = 8 per
lls) in Ltbr+/ and Ltbr/mice (n = 4 per genotype).
m.
r genotype). Statistical data are shown as the mean
November 5, 2015 ª2015 Elsevier Inc. 985
ELISA
The autoantibodies in the mouse serum were analyzed using ELISA kits
(Southern Biotech) and quantified with a plate reader (BioRAD iMark Micro-
plate Reader), as previously described (Komatsu et al., 2014). Mouse recom-
binant proteins were transthyretin (Uscn, RPA726Mu01), monoamine oxidase
a (Usbio, 155899), calbindin (Uscn, RPG438Mu01), and interstitial retinol bind-
ing protein (Uscn, RPA367Mu01).
Statistical Analysis
Statistical analysis was performed using one-way ANOVA followed by post
hoc Bonferroni test when applicable or unpaired two-tailed t test (*p < 0.05;
**p < 0.01; ***p < 0.001; NS, not significant, throughout the paper). All data
are expressed as the mean ± SD. Results are representative of more than
two independent experiments.
Detailed methods can be found in the Supplemental Information.ACCESSION NUMBERS
Data were analyzed using GeneSpring and deposited in the GEO database un-
der accession number GSE69105.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and two tables and can be found with this article online at http://
dx.doi.org/10.1016/j.cell.2015.10.013.
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